Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection

Emergencies Clinical Trial

— RECOP  

Official title:

Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection (Unit "COVID Possible")

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04371328
• Other study ID #: RC31/20/0094
• Status: Completed
• Start date: March 13, 2020
• Est. completion date: June 30, 2020

Study information

• Verified date: October 2021
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This research aims to improve knowledge of the epidemiology of patients consulting in the COvid Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. It will be necessary to identify the diagnosis of the dyspneic patient and to define his virological status COVID before referring him to the appropriate units.

The investigatory propose an original strategy of dedicating entire care sectors to the care of patients admitted for dyspnea in our ER. These units will be named RECOP units.

This study would improve epidemiological knowledge of COVID-19 and ability to receive these patients within the SU.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1860
• Est. completion date: June 30, 2020
• Est. primary completion date: June 5, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria:

• All patients over the age of 15 admitted to the RECOP unit for dyspnea

Exclusion Criteria:

• Patient admitted to shock for respiratory distress requiring immediate respiratory support.

• Patient under justice safeguard

Related Conditions & MeSH terms

• COVID-19
• Emergencies

Intervention

Other:
• RECOP unit patient
All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified. 30 days after inclusion, virological status and mortality will be collect

Locations

Country	Name	City	State
France	University Hospital of Toulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Virological status	Virological status will be collected by a phone call at the patient	30 days
Other	Mortality status	Mortality status will be collected by a phone call at the patient	30 days
Primary	Describe the characteristics of patients admitted to reCOP units according to their virological status vis-à-vis COVID-19	The virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking	30 days
Secondary	Develop a predictive model of the risk of being COVID for patients admitted to the emergency room for dyspnea	demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor	0 days